Clinical trial
The OMEGA Study: Use of Eye Drops to Treat Geographic Atrophy Associated With…
NCT00485394 · Othera Pharmaceuticals, Industry · Unknown status
Key facts
| NCT number | NCT00485394 |
|---|---|
| Title | The OMEGA Study: Use of Eye Drops to Treat Geographic Atrophy Associated With Age-Related Macular Degeneration (Dry AMD) |
| Official title | A Randomized, Double-Masked, Dose-Ranging, Multi-Center, Phase II Study Comparing the Safety and Efficacy of OT-551 With Placebo to Treat Geographic Atrophy Associated With Age-Related Macular Degeneration |
| Acronym | OMEGA |
| Lead sponsor | Othera Pharmaceuticals, Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Age-Related Macular Degeneration |
| Intervention type | Drug |
| Interventions | OT-551, vehicle placebo |
| Enrollment | 198 |
| Start date | Jun 1, 2007 |
| Primary completion | Feb 1, 2010 |
| First posted | Jun 13, 2007 |
| Last update posted | Apr 2, 2008 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: